SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for GSK (GSK) — Jul 14, 2014

GSK plc
Date: July 14, 2014 · CIK: 0001131399 · Accession: 0000000000-14-035252

AI Filing Summary & Sentiment

Date
December 31, 2013
Author
/s/ Joel Parker
Form
UPLOAD
Company
GSK plc

Letter

July 11 , 201 4 Via E -mail Mr. Simon Dingemans Chief Financial Officer GlaxoSmithKline plc 980 Great West Road Brentford, Middlesex TW8 9GS England

Re: GlaxoSmithKline plc Form 2 0-F for Fis cal Year Ended December 31, 2013 Filed February 28, 2014 File No. 001 -15170

Dear Mr. Dingemans :

We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Joel Parker

Show Raw Text
July 11 , 201 4

Via E -mail
Mr. Simon Dingemans
Chief Financial  Officer
GlaxoSmithKline plc
980 Great West Road
Brentford, Middlesex
TW8 9GS England

Re: GlaxoSmithKline plc
  Form 2 0-F for Fis cal Year Ended December 31, 2013
Filed February 28, 2014
  File No. 001 -15170

Dear  Mr. Dingemans :

We have completed our review of your filing. We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States. We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ Joel Parker

Joel Parker
Accounting Branch Chief